Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACs

Min, Jaeki; Mayasundari, Anand; Keramatnia, Fatemeh; Jonchere, Barbara; Yang, Seung Wook; Jarusiewicz, Jamie; Actis, Marisa; Das, Sourav; Young, Brandon; Slavish, Jake; Yang, Lei; Li, Yong; Fu, Xiang; Garrett, Shalandus H.; Yun, Mi-Kyung; Li, Zhenmei; Nithianantham, Stanley; Chai, Sergio; Chen, Taosheng; Shelat, Anang; Lee, Richard E.; Nishiguchi, Gisele; White, Stephen W.; Roussel, Martine F.; Potts, Patrick Ryan; Fischer, Marcus; Rankovic, Zoran

doi:10.1002/anie.202108848

Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACs

Journal Article · 01 December 2021 · Angew. Chem. Int. Ed.

DOI:https://doi.org/10.1002/anie.202108848· OSTI ID:1844730

Min, Jaeki; Mayasundari, Anand; Keramatnia, Fatemeh; Jonchere, Barbara; Yang, Seung Wook; Jarusiewicz, Jamie; Actis, Marisa; Das, Sourav; Young, Brandon; Slavish, Jake; Yang, Lei; Li, Yong; Fu, Xiang; Garrett, Shalandus H.; Yun, Mi-Kyung; Li, Zhenmei; Nithianantham, Stanley; Chai, Sergio; Chen, Taosheng; Shelat, Anang more »

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; NCI

OSTI ID:: 1844730

Journal Information:: Angew. Chem. Int. Ed., Vol. 60, Issue (51)

Country of Publication:: United States

Language:: ENGLISH

References (32)

Identification of a Primary Target of Thalidomide Teratogenicity Ito, T.; Ando, H.; Suzuki, T. Science, Vol. 327, Issue 5971 https://doi.org/10.1126/science.1177319	journal	March 2010
Critical Assessment of Targeted Protein Degradation as a Research Tool and Pharmacological Modality Kostic, Milka; Jones, Lyn H. Trends in Pharmacological Sciences, Vol. 41, Issue 5 https://doi.org/10.1016/j.tips.2020.02.006	journal	May 2020
Development of targeted protein degradation therapeutics Chamberlain, Philip P.; Hamann, Lawrence G. Nature Chemical Biology, Vol. 15, Issue 10 https://doi.org/10.1038/s41589-019-0362-y	journal	September 2019
Cereblon modulators: Low molecular weight inducers of protein degradation Chamberlain, Philip P.; Cathers, Brian E. Drug Discovery Today: Technologies, Vol. 31 https://doi.org/10.1016/j.ddtec.2019.02.004	journal	April 2019
Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon Modulators Nishiguchi, Gisele; Keramatnia, Fatemeh; Min, Jaeki Journal of Medicinal Chemistry, Vol. 64, Issue 11 https://doi.org/10.1021/acs.jmedchem.0c01313	journal	May 2021
Targeted protein degradation: expanding the toolbox Schapira, Matthieu; Calabrese, Matthew F.; Bullock, Alex N. Nature Reviews Drug Discovery, Vol. 18, Issue 12 https://doi.org/10.1038/s41573-019-0047-y	journal	October 2019
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN Sievers, Quinlan L.; Petzold, Georg; Bunker, Richard D. Science, Vol. 362, Issue 6414 https://doi.org/10.1126/science.aat0572	journal	November 2018
Targeted protein degradation: elements of PROTAC design Paiva, Stacey-Lynn; Crews, Craig M. Current Opinion in Chemical Biology, Vol. 50 https://doi.org/10.1016/j.cbpa.2019.02.022	journal	June 2019
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation Sakamoto, K. M.; Kim, K. B.; Kumagai, A. Proceedings of the National Academy of Sciences, Vol. 98, Issue 15 https://doi.org/10.1073/pnas.141230798	journal	July 2001
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4 Lu, Jing; Qian, Yimin; Altieri, Martha Chemistry & Biology, Vol. 22, Issue 6 https://doi.org/10.1016/j.chembiol.2015.05.009	journal	June 2015
Phthalimide conjugation as a strategy for in vivo target protein degradation Winter, G. E.; Buckley, D. L.; Paulk, J. Science, Vol. 348, Issue 6241 https://doi.org/10.1126/science.aab1433	journal	May 2015
Small-molecule PROTAC degraders of the Bromodomain and Extra Terminal (BET) proteins — A review Yang, Chao-Yie; Qin, Chong; Bai, Longchuan Drug Discovery Today: Technologies, Vol. 31 https://doi.org/10.1016/j.ddtec.2019.04.001	journal	April 2019
The Metabolism of Thalidomide: the fate of Thalidomide and some of its Hydrolysis Products in Various Species Schumacher, H.; Smith, R. L.; Williams, R. T. British Journal of Pharmacology and Chemotherapy, Vol. 25, Issue 2 https://doi.org/10.1111/j.1476-5381.1965.tb02054.x	journal	October 1965
The Metabolism of Thalidomide: the Spontaneous Hydrolysis of Thalidomide in Solution Schumacher, H.; Smith, R. L.; Williams, R. T. British Journal of Pharmacology and Chemotherapy, Vol. 25, Issue 2 https://doi.org/10.1111/j.1476-5381.1965.tb02053.x	journal	October 1965
Efficient Synthesis of Immunomodulatory Drug Analogues Enables Exploration of Structure–Degradation Relationships Burslem, George M.; Ottis, Philipp; Jaime‐Figueroa, Saul ChemMedChem, Vol. 13, Issue 15 https://doi.org/10.1002/cmdc.201800271	journal	July 2018
CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL Hagner, Patrick R.; Man, Hon-Wah; Fontanillo, Celia Blood, Vol. 126, Issue 6 https://doi.org/10.1182/blood-2015-02-628669	journal	August 2015
CC-90009, a Novel Cereblon E3 Ligase Modulator, Targets GSPT1 for Degradation to Induce Potent Tumoricidal Activity Against Acute Myeloid Leukemia (AML) Lopez-Girona, Antonia; Lu, Gang; Rychak, Emily Blood, Vol. 134, Issue Supplement_1 https://doi.org/10.1182/blood-2019-127892	journal	November 2019
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase Matyskiela, Mary E.; Lu, Gang; Ito, Takumi Nature, Vol. 535, Issue 7611 https://doi.org/10.1038/nature18611	journal	June 2016
Clinical Activity of CC-90009, a Cereblon E3 Ligase Modulator and First-in-Class GSPT1 Degrader, As a Single Agent in Patients with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML): First Results from a Phase I Dose-Finding Study Uy, Geoffrey L.; Minden, Mark D.; Montesinos, Pau Blood, Vol. 134, Issue Supplement_1 https://doi.org/10.1182/blood-2019-123966	journal	November 2019
A novel cereblon modulator for targeted protein degradation Kim, Sung Ah; Go, Ara; Jo, Seung-Hyun European Journal of Medicinal Chemistry, Vol. 166 https://doi.org/10.1016/j.ejmech.2019.01.023	journal	March 2019
Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide Fischer, Eric S.; Böhm, Kerstin; Lydeard, John R. Nature, Vol. 512, Issue 7512 https://doi.org/10.1038/nature13527	journal	July 2014
Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766) Chessum, Nicola E. A.; Sharp, Swee Y.; Caldwell, John J. Journal of Medicinal Chemistry, Vol. 61, Issue 3 https://doi.org/10.1021/acs.jmedchem.7b01406	journal	January 2018
Ligand efficiency: a useful metric for lead selection Hopkins, Andrew L.; Groom, Colin R.; Alex, Alexander Drug Discovery Today, Vol. 9, Issue 10 https://doi.org/10.1016/S1359-6446(04)03069-7	journal	May 2004
Chiral Inversion and Hydrolysis of Thalidomide: Mechanisms and Catalysis by Bases and Serum Albumin, and Chiral Stability of Teratogenic Metabolites Reist, Marianne; Carrupt, Pierre-Alain; Francotte, Eric Chemical Research in Toxicology, Vol. 11, Issue 12 https://doi.org/10.1021/tx9801817	journal	November 1998
HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment Milde, Till; Lodrini, Marco; Savelyeva, Larissa Journal of Neuro-Oncology, Vol. 110, Issue 3 https://doi.org/10.1007/s11060-012-0978-1	journal	October 2012
Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression Qin, Chong; Hu, Yang; Zhou, Bing Journal of Medicinal Chemistry, Vol. 61, Issue 15 https://doi.org/10.1021/acs.jmedchem.8b00506	journal	July 2018
Enhancing Antiproliferative Activity and Selectivity of a FLT-3 Inhibitor by Proteolysis Targeting Chimera Conversion Burslem, George M.; Song, Jayoung; Chen, Xin Journal of the American Chemical Society, Vol. 140, Issue 48 https://doi.org/10.1021/jacs.8b10320	journal	November 2018
Protein targeting chimeric molecules specific for dual bromodomain 4 (BRD4) and Polo-like kinase 1 (PLK1) proteins in acute myeloid leukemia cells Mu, Xupeng; Bai, Liting; Xu, Yingju Biochemical and Biophysical Research Communications, Vol. 521, Issue 4 https://doi.org/10.1016/j.bbrc.2019.11.007	journal	January 2020
Development of BODIPY FL Thalidomide As a High-Affinity Fluorescent Probe for Cereblon in a Time-Resolved Fluorescence Resonance Energy Transfer Assay Lin, Wenwei; Li, Yongtao; Min, Jaeki Bioconjugate Chemistry, Vol. 31, Issue 11 https://doi.org/10.1021/acs.bioconjchem.0c00507	journal	October 2020
Structural basis of PROTAC cooperative recognition for selective protein degradation Gadd, Morgan S.; Testa, Andrea; Lucas, Xavier Nature Chemical Biology, Vol. 13, Issue 5 https://doi.org/10.1038/nchembio.2329	journal	March 2017
Proteolysis targeting chimeras (PROTACs) in ‘beyond rule-of-five’ chemical space: Recent progress and future challenges Edmondson, Scott D.; Yang, Bin; Fallan, Charlene Bioorganic & Medicinal Chemistry Letters, Vol. 29, Issue 13 https://doi.org/10.1016/j.bmcl.2019.04.030	journal	July 2019
Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma Venkataraman, Sujatha; Alimova, Irina; Balakrishnan, Ilango Oncotarget, Vol. 5, Issue 9 https://doi.org/10.18632/oncotarget.1659	journal	March 2014

Similar Records

Design of a PROTAC that antagonizes and destroys the cancer-forming X-protein of the hepatitis B virus

Journal Article · 2014 · Biochemical and Biophysical Research Communications · OSTI ID:22416812

Montrose, Kristopher

Integrated Design of Ultradurable, Low CO₂ Alternative Binder Systems via Machine Learning

Technical Report · 2023 · OSTI ID:1973517

Washburn, Newell; Kurtis, Kimberly; Poczos, Barnabas; +2 more

Advances in alternative cementitious binders

Journal Article · 2011 · Cement and Concrete Research · OSTI ID:21576903

Juenger, M C.G.,; Winnefeld, F; Provis, J L; +1 more

Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACs

Citation Formats

References (32)

Similar Records

Related Subjects